Synthesis of diacylglycerol analogues as potential second-messenger antagonists and inhibitors of protein kinase C. 1992

J C Briggs, and A H Haines, and R J Taylor, and A P Dawson, and I Gibson, and J Hook, and A Lloyd, and S Meiners
School of Chemical Sciences, University of East Anglia, Norwich, United Kingdom.

A series of analogues of diacylglycerol has been prepared and tested as inhibitors of protein kinase C (PKC). The diketone analogues, 10-hydroxymethyl-8,13-eicosanedione (24), 10-acetoxymethyl-8,13-eicosanedione (25), and 10-methoxymethyl-8,13-eicosanedione (26) each inhibited PKC activated by 2-O-acetyl-1-O-oleoylglycerol. Compound 24 was the most effective inhibitor of the growth of MR4 and HT29 cells in culture, and 26 was more effective than 24 against HL60 cells.

UI MeSH Term Description Entries
D011493 Protein Kinase C An serine-threonine protein kinase that requires the presence of physiological concentrations of CALCIUM and membrane PHOSPHOLIPIDS. The additional presence of DIACYLGLYCEROLS markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by PHORBOL ESTERS and it is believed that protein kinase C is the receptor protein of tumor-promoting phorbol esters. Calcium Phospholipid-Dependent Protein Kinase,Calcium-Activated Phospholipid-Dependent Kinase,PKC Serine-Threonine Kinase,Phospholipid-Sensitive Calcium-Dependent Protein Kinase,Protein Kinase M,Calcium Activated Phospholipid Dependent Kinase,Calcium Phospholipid Dependent Protein Kinase,PKC Serine Threonine Kinase,Phospholipid Sensitive Calcium Dependent Protein Kinase,Phospholipid-Dependent Kinase, Calcium-Activated,Serine-Threonine Kinase, PKC
D004075 Diglycerides Glycerides composed of two fatty acids esterified to the trihydric alcohol GLYCEROL. There are two possible forms that exist: 1,2-diacylglycerols and 1,3-diacylglycerols. Diacylglycerol,Diacylglycerols
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001681 Biological Assay A method of measuring the effects of a biologically active substance using an intermediate in vivo or in vitro tissue or cell model under controlled conditions. It includes virulence studies in animal fetuses in utero, mouse convulsion bioassay of insulin, quantitation of tumor-initiator systems in mouse skin, calculation of potentiating effects of a hormonal factor in an isolated strip of contracting stomach muscle, etc. Bioassay,Assay, Biological,Assays, Biological,Biologic Assay,Biologic Assays,Assay, Biologic,Assays, Biologic,Bioassays,Biological Assays
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D015290 Second Messenger Systems Systems in which an intracellular signal is generated in response to an intercellular primary messenger such as a hormone or neurotransmitter. They are intermediate signals in cellular processes such as metabolism, secretion, contraction, phototransduction, and cell growth. Examples of second messenger systems are the adenyl cyclase-cyclic AMP system, the phosphatidylinositol diphosphate-inositol triphosphate system, and the cyclic GMP system. Intracellular Second Messengers,Second Messengers,Intracellular Second Messenger,Messenger, Second,Messengers, Intracellular Second,Messengers, Second,Second Messenger,Second Messenger System,Second Messenger, Intracellular,Second Messengers, Intracellular,System, Second Messenger,Systems, Second Messenger
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

J C Briggs, and A H Haines, and R J Taylor, and A P Dawson, and I Gibson, and J Hook, and A Lloyd, and S Meiners
April 1989, Biochemical Society transactions,
J C Briggs, and A H Haines, and R J Taylor, and A P Dawson, and I Gibson, and J Hook, and A Lloyd, and S Meiners
July 1990, The Biochemical journal,
J C Briggs, and A H Haines, and R J Taylor, and A P Dawson, and I Gibson, and J Hook, and A Lloyd, and S Meiners
January 2000, Medicina,
J C Briggs, and A H Haines, and R J Taylor, and A P Dawson, and I Gibson, and J Hook, and A Lloyd, and S Meiners
June 1986, Cell,
J C Briggs, and A H Haines, and R J Taylor, and A P Dawson, and I Gibson, and J Hook, and A Lloyd, and S Meiners
July 2004, Journal of medicinal chemistry,
J C Briggs, and A H Haines, and R J Taylor, and A P Dawson, and I Gibson, and J Hook, and A Lloyd, and S Meiners
June 1995, Journal of neurophysiology,
J C Briggs, and A H Haines, and R J Taylor, and A P Dawson, and I Gibson, and J Hook, and A Lloyd, and S Meiners
March 1989, Journal of medicinal chemistry,
J C Briggs, and A H Haines, and R J Taylor, and A P Dawson, and I Gibson, and J Hook, and A Lloyd, and S Meiners
February 2020, RSC advances,
J C Briggs, and A H Haines, and R J Taylor, and A P Dawson, and I Gibson, and J Hook, and A Lloyd, and S Meiners
May 2004, Bioorganic & medicinal chemistry,
J C Briggs, and A H Haines, and R J Taylor, and A P Dawson, and I Gibson, and J Hook, and A Lloyd, and S Meiners
August 2017, Bioconjugate chemistry,
Copied contents to your clipboard!